Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference103 articles.
1. STATs in cancer inflammation and immunity: a leading role for STAT3;Yu;Nat. Rev. Cancer,2009
2. The STATs of cancer – new molecular targets come of age;Yu;Nat. Rev. Cancer,2004
3. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6;Zhong;Science,1994
4. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway;Akira;Cell,1994
5. STAT3: a novel molecular mediator of resistance to chemoradiotherapy;Spitzner;Cancers,2014
Cited by 202 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy;Biomaterials;2025-02
2. A hierarchical attention network integrating multi-scale relationship for drug response prediction;Information Fusion;2024-10
3. Induction, growth, drug resistance, and metastasis: A comprehensive summary of the relationship between STAT3 and gastric cancer;Heliyon;2024-09
4. Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma;International Journal of Pharmaceutics;2024-08
5. Pyrimidine compounds BY4003 and BY4008 inhibit glioblastoma cells growth via modulating JAK3/STAT3 signaling pathway;Neurotherapeutics;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3